ARCHIVES

Tivozanib Does Not Improve OS Compared to Sorafenib

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

COG’s Peter Adamson Has A Conversation With The Cancer Letter

March 15, 2013

Surveillance Following Surgery Sufficient in Stage I Seminoma

May 31, 2013

Obey Erred On Criticism Of Pap Test Cost, FCRC Construction

August 10, 1979

Katterhagen Predicts Increase Support From State, Local sources, Sees It As Community Challenge

March 27, 1981

In Brief NCI-FDA Relations Tops, DeVita Says; Upon Talks to Candidates For Prospective Division

November 24, 1978

Only 10% Of Breast Cancer Patients May Benefit From Contralateral Mastectomy

March 26, 2010